Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V - comparable to codeine-containing cough syrups - indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. "With [...]